Skip to main content
. 2020 Jan 23;106(1):87–97. doi: 10.3324/haematol.2019.239947

Figure 1.

Figure 1.

Overview of copy-number alterations detected by genomic arrays. (A) Percentages of patients with del(13)(q14), del(11)(q22.3) (ATM), trisomy 12 (+12) or del(17)(p13.1) (TP53) detected by genomic arrays irrespective of size. (B-E) Percentages of patients with different chromosomal losses (B), gains (C), monosomies (D) and trisomies (E). (F) Percentages of patients with putative chromothripsis events containing TP53abn in black and cases without TP53abn but del(11q)-positive in white. In four del(11q) cases, TP53 mutation status was not determined.